Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price ▲ | Potential |
|---|---|---|---|---|---|---|---|
| Stratec SE | 2 | 0 | 0 | 0 | €43.30 | - | - |
| Aldeyra Therapeutics Inc. | 2 | 0 | 0 | 0 | €3.87 | - | - |
| Immunogen Inc. | 5 | 0 | 1 | 0 | €28.97 | - | - |
| Trinity Biotech ADR | 22 | 0 | 1 | 0 | €0.41 | - | - |
| Pro-Dex Inc. | 15 | 0 | 0 | 0 | €16.10 | - | - |
| Enlivex Therapeutics Ltd. | 1 | 0 | 1 | 0 | €1.43 | - | - |
| Brainstorm Cell | 1 | 0 | 0 | 0 | €0.35 | - | - |
| Bastide Le Confort | 1 | 0 | 1 | 0 | €19.76 | - | - |
| Vericel Corp. | 1 | 0 | 0 | 0 | €43.80 | - | - |
| Omeros Corp. | 2 | 4 | 0 | 0 | €3.36 | - | - |
| Natural Alternat. | 17 | 1 | 0 | 0 | €5.75 | - | - |
| Virbac S.A. | 1 | 0 | 0 | 0 | €353.50 | - | - |
| ProQR Therapeutics N.V. | 6 | 0 | 1 | 0 | €1.83 | €2.81 | 53.481% |
| SCYNEXIS Inc. | 5 | 0 | 0 | 0 | €1.66 | €3.00 | 80.723% |
| Aclaris Therapeutics Inc | 1 | 0 | 1 | 0 | €1.22 | €3.00 | 144.998% |
| Cerus Corp. | 4 | 0 | 2 | 0 | €1.69 | €3.26 | 92.909% |
| Akebia Therapeutics Inc. | 8 | 3 | 1 | 0 | €1.39 | €3.60 | 159.675% |
| Compugen Ltd. | 3 | 2 | 1 | 0 | €2.01 | €3.67 | 82.813% |
| Cutera Inc. | 2 | 0 | 1 | 0 | €2.89 | €3.75 | 29.983% |
| Xeris Biopharma Holdings Inc. | 4 | 0 | 0 | 0 | €1.76 | €4.39 | 149.506% |
| Heron Therapeutics Inc. | 9 | 1 | 4 | 0 | €2.64 | €4.57 | 73.119% |
| Geron Corp. | 12 | 0 | 4 | 0 | €3.58 | €4.63 | 29.068% |
| Cara Therapeutics Inc. | 8 | 1 | 1 | 0 | €0.73 | €4.63 | 535.456% |
| Adverum Biotechnologies Inc. | 6 | 1 | 2 | 0 | €1.38 | €4.66 | 237.768% |
| Vanda Pharmaceuticals | 4 | 0 | 1 | 0 | €4.96 | €5.00 | 0.806% |